Valneva SE (VALN) Inventory Average (2022 - 2026)
Valneva SE (VALN) posted Inventory Average of $58.8 million for Q1 2026, down 11.93% sequentially from $66.8 million in Q4 2025, and down 3.71% YoY from $61.1 million in Q1 2025.
Analysis
Valneva SE (VALN) Inventory Average (2022 - 2026) Analysis & Trends
Valneva SE has reported Inventory Average for 5 years, with the latest figure at $58.8 million in Q1 2026.
- Quarterly Inventory Average fell 3.71% year-over-year to $58.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.8 million (down 3.71% YoY) and the FY2025 annual result came in at $58.3 million, up 9.77% from the prior year.
- Inventory Average retreated to $58.8 million in Q1 2026 per VALN's latest filing, from $66.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $149.4 million in Q1 2022 and troughed at $38.8 million in Q1 2023.
- A 5-year average of $67.9 million and a median of $60.4 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2024: Inventory Average tumbled 74.0% in 2023, then soared 49.49% in 2024.
- Over 5 years, Inventory Average stood at $66.5 million in 2022, then plunged by 32.96% to $44.6 million in 2023, then surged by 35.47% to $60.4 million in 2024, then gained by 10.57% to $66.8 million in 2025, then declined by 11.93% to $58.8 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $58.8 million, $66.8 million, and $72.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | 57.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.60 Mn |
| Mar 31, 2026 | 58.85 Mn |
| Dec 31, 2025 | 66.82 Mn |
| Sep 30, 2025 | 72.52 Mn |
| Jun 30, 2025 | 67.38 Mn |
| Mar 31, 2025 | 61.11 Mn |
| Dec 31, 2024 | 60.43 Mn |
| Sep 30, 2024 | 58.07 Mn |
| Jun 30, 2024 | 52.70 Mn |
| Mar 31, 2024 | 50.31 Mn |
| Dec 31, 2023 | 44.60 Mn |
| Sep 30, 2023 | 38.84 Mn |
| Jun 30, 2023 | 39.09 Mn |
| Mar 31, 2023 | 38.84 Mn |
| Dec 31, 2022 | 66.54 Mn |
| Sep 30, 2022 | 99.42 Mn |
| Jun 30, 2022 | 129.20 Mn |
| Mar 31, 2022 | 149.39 Mn |